Depression is one of the common psychiatric disorders in old age. Major depressive disorder (MDD) has been identified as a risk factor or prodrome for neurodegenerative dementias, suggesting neuropathological overlaps and a continuum between MDD and neurodegenerative disorders. In this study, we examined tau and amyloid-β (Aβ) accumulations in the brains of MDD and healthy controls using positron emission tomography (PET) to explore pathological substrates of this illness. Twenty MDD and twenty age-matched, healthy controls were examined by PET with a tau radioligand, [11C]PBB3, and an Aβ radioligand, [11C]PiB. Radioligand retentions were quantified as a standardized uptake value ratio (SUVR). We also assessed clinical manifestations of the...
In addition to the deposition of β-amyloid plaques, neurofibrillary tangles composed of aggregated h...
The metabotropic glutamate receptor subtype 5 (mGluR5) has been implicated in the pathophysiology of...
Late-life depression (LLD) and Alzheimer's Disease (AD) are the two most frequent neuropsychiatric d...
Tau PET is a molecular imaging technique to detect accumulation of tau aggregates in neurodegenerati...
BackgroundDepressive symptoms predict increased risk for dementia decades before the emergence of co...
BackgroundNeurotoxicity associated with amyloid and tau protein aggregation could represent a pathop...
BACKGROUND: Neurotoxicity associated with amyloid and tau protein aggregation could represent a path...
Tau pathology is a hallmark of Alzheimer's disease (AD) but also occurs in normal cognitive aging. U...
Mild cognitive impairment (MCI) may interact with depression to mediate the risk of developing Alzhe...
Tau pathology is a hallmark of Alzheimer’s disease (AD) but also occurs in normal cognitive aging. U...
Abstract Late-life depression (LLD) is associated with a risk of developing Alzheimer’s disease (AD)...
Late-life late onset depression (i.e., depression with an age of onset above 60yrs) appears to diffe...
The development of tau-specific positron emission tomography (PET) tracers allows imaging in vivo th...
Background and aims:[11C]PBB3 is a novel tau imaging PET ligand, showing high affinity and selectivi...
The advent of PET ligands that bind tau pathology has enabled the quantification and visualization o...
In addition to the deposition of β-amyloid plaques, neurofibrillary tangles composed of aggregated h...
The metabotropic glutamate receptor subtype 5 (mGluR5) has been implicated in the pathophysiology of...
Late-life depression (LLD) and Alzheimer's Disease (AD) are the two most frequent neuropsychiatric d...
Tau PET is a molecular imaging technique to detect accumulation of tau aggregates in neurodegenerati...
BackgroundDepressive symptoms predict increased risk for dementia decades before the emergence of co...
BackgroundNeurotoxicity associated with amyloid and tau protein aggregation could represent a pathop...
BACKGROUND: Neurotoxicity associated with amyloid and tau protein aggregation could represent a path...
Tau pathology is a hallmark of Alzheimer's disease (AD) but also occurs in normal cognitive aging. U...
Mild cognitive impairment (MCI) may interact with depression to mediate the risk of developing Alzhe...
Tau pathology is a hallmark of Alzheimer’s disease (AD) but also occurs in normal cognitive aging. U...
Abstract Late-life depression (LLD) is associated with a risk of developing Alzheimer’s disease (AD)...
Late-life late onset depression (i.e., depression with an age of onset above 60yrs) appears to diffe...
The development of tau-specific positron emission tomography (PET) tracers allows imaging in vivo th...
Background and aims:[11C]PBB3 is a novel tau imaging PET ligand, showing high affinity and selectivi...
The advent of PET ligands that bind tau pathology has enabled the quantification and visualization o...
In addition to the deposition of β-amyloid plaques, neurofibrillary tangles composed of aggregated h...
The metabotropic glutamate receptor subtype 5 (mGluR5) has been implicated in the pathophysiology of...
Late-life depression (LLD) and Alzheimer's Disease (AD) are the two most frequent neuropsychiatric d...